Swipe here for more
Cancer treatments represented 33 per cent of medicines in all phases of clinical trials in 2023, followed by treatments for infectious diseases (13 per cent) and central nervous system diseases (12 per cent), according to a new report by the Patented Medicine Prices Review Board.
The Weekly Dose
Your essential briefing on health care and medical news. Sign up to get it next Sunday.
Check out our newsletter, The Weekly Dose – it's a handpicked roundup of the most important news from the week. Subscribe